This study is testing whether adding a digital therapy device to standard anxiety medication works better than medication alone. It involves 162 adults with moderate to severe anxiety. The goal is to see if the combination reduces anxiety symptoms more effectively over 12 weeks.
Phase: PHASE3 • Sponsor: Psicofarma, S.A. De C.V. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC